Zia Choudhry Launchs a New Digital Education Platform Designed to Inform and Empower People Living With wAIHA
Zia Choudhry, Senior Medical Director Rare Autoantibody Diseases – Immunology at Johnson & Johnson Innovative Medicine, shared a post on LinkedIn:
“At Johnson & Johnson Innovative Medicine, we’re committed to ensuring every patient’s voice is heard and their needs are prioritized. That’s why I’m excited to share the launch of MywAIHAHome.com — a new digital education platform designed to inform and empower people living with warm autoimmune hemolytic anemia (wAIHA) and their care partners.
Because we believe meaningful engagement with the patient community is key to advancing healthcare, in collaboration with patient advocates and healthcare professionals we conducted qualitative research to better understand the needs and preferences of individuals living with wAIHA. Our goal? To develop educational resources that are truly impactful, accessible, and tailored to the patient journey.
At this week’s National Organization for Rare Disorders Breakthrough Summit, I’m proud to be presenting the findings of our research, which highlighted the importance of reliable, easy-to-understand information, support networks, and patient testimonials. Let’s connect if you’re at this week’s meeting in Washington, D.C., or please be sure to visit MywAIHAHome.com today to see what we can achieve when we put patients first.”
Stay informed with Hemostasis Today.
-
Aug 26, 2026, 16:53Chokri Ben Lamine: Antiphospholipid Syndrome After Kidney Transplantation
-
Aug 26, 2026, 16:32Kai Rejeski: Why TP53 Mutations May Define a Higher-Risk CAR-T Population
-
Aug 26, 2026, 16:20Ons Marsit: Impact of Electroanatomical Mapping on Pentaspline Pulsed Field Ablation
-
Aug 26, 2026, 16:18Sam Mbunya: Celebrating Cyrus Njuguna Githinji’s New Leadership Role in Haemophilia Care
-
Aug 26, 2026, 15:48Melissa Hollo: Postpartum Depression is More Than the “Baby Blues”
-
Aug 26, 2026, 15:46Raghavendra Rao: The Link Between Neuropathy and Chronic Venous Disease
-
Aug 26, 2026, 15:43Laurent Bertoletti: Long Term Benefits and Safety of Rehabilitation in Pulmonary Arterial Hypertension
-
Aug 26, 2026, 15:41Tamer Hellou: Chromosome 1q Gain Signals High Long-Term Risk in AL Amyloidosis
-
Aug 26, 2026, 15:04Sequential Efgartigimod and Eltrombopag Achieve Durable Response in Refractory ITP – Platelets Journal